Loading insider details...
Beta
Latest Form 4 (Jul 22, 2026): Conversion of 2,066,250 FRNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 22, 2026 | Freenome, Inc. (FRNM) | Conversion | 2,066,250 | n/a |
| Oct 1, 2024 | Adagio Medical Holdings, Inc. (ADGM) | Other (see footnotes) | 3,501,600 | n/a |
| Jul 31, 2024 | ARYA Sciences Acquisition Corp IV (ARYD) | Disposition to Issuer | 499,000 | n/a |
| Jun 17, 2024 | Nautilus Biotechnology, Inc. (NAUT) | Grant/Award | 45,000 | n/a |
| Jun 14, 2024 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 30,000 | n/a |
| Jun 13, 2024 | Perceptive Capital Solutions Corp (PCSC) | Grant/Award | 286,250 | $2.86M |
| Jul 6, 2023 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 20,000 | n/a |
| Jun 21, 2023 | Nautilus Biotechnology, Inc. (NAUT) | Grant/Award | 45,000 | n/a |
| Jun 21, 2022 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 7,250 | n/a |
| Jun 17, 2022 | Nautilus Biotechnology, Inc. (NAUT) | Grant/Award | 86,467 | n/a |